Publication:
Updated overall survival (OS) results from the first-line (1L) population in the phase III MONALEESA-3 trial of postmenopausal patients (PTS) with HR+/HER2-advanced breast cancer (ABC) treated with ribociclib (RIB) plus fulvestrant (FUL)

Simple item page
dc.conference.dateMAY 03-05, 2022
dc.conference.titleEuropean-Society-for-Medical-Oncology (ESMO) Breast Cancer Congress
dc.contributor.authorNeven, P.
dc.contributor.authorFasching, P. A.
dc.contributor.authorChia, S.
dc.contributor.authorJerusalem, G.
dc.contributor.authorDe laurentiis, M.
dc.contributor.authorIm, S. -A.
dc.contributor.authorPetrakova, K.
dc.contributor.authorBianchi, G. V.
dc.contributor.authorMartin Jimenez, M.
dc.contributor.authorNusch, A.
dc.contributor.authorSonke, G. S.
dc.contributor.authorde la Cruz Merino, L.
dc.contributor.authorBeck, J. T.
dc.contributor.authorZarate, J. P.
dc.contributor.authorWang, Y.
dc.contributor.authorChakravartty, A.
dc.contributor.authorWang, C.
dc.contributor.authorSlamon, D.
dc.contributor.authoraffiliation[Neven, P.] Univ Hosp Leuven Campus Gasthuisberg, Dept Gynaecol Oncol, Multidisciplinary Breast Ctr, Leuven, Belgium
dc.contributor.authoraffiliation[Fasching, P. A.] Univ Hosp Erlangen, Dept Gynecol & Obstet, Comprehens Canc Ctr Erlangen EMN, Erlangen, Germany
dc.contributor.authoraffiliation[Chia, S.] BC Canc Agcy Vancouver, BC Canc, Vancouver, BC, Canada
dc.contributor.authoraffiliation[Jerusalem, G.] Ctr Hosp Univ Sart Tilman, Dept Med Oncol, Liege, Belgium
dc.contributor.authoraffiliation[De laurentiis, M.] Ist Nazl Tumori IRCCS Fdn Pascale, Dept Breast & Thorac Oncol, Naples, Italy
dc.contributor.authoraffiliation[Im, S. -A.] Seoul Natl Univ, Canc Res Inst, Dept Internal Med, Coll Med, Seoul, South Korea
dc.contributor.authoraffiliation[Petrakova, K.] Masaryk Mem Canc Inst, Dept Med Oncol, Brno, Czech Republic
dc.contributor.authoraffiliation[Bianchi, G. V.] Ist Nazl Tumori Milano Fdn IRCCS, Med Oncol, Milan, Italy
dc.contributor.authoraffiliation[Martin Jimenez, M.] Hosp Gen Univ Gregorio Maranon, Med Oncol Serv, Madrid, Spain
dc.contributor.authoraffiliation[Nusch, A.] Onkol Praxis Velbert, Oncol, Velbert, Germany
dc.contributor.authoraffiliation[Sonke, G. S.] NKI AVL Netherlands Canc Inst Antoni van Leeuwenh, Oncol, Amsterdam, Netherlands
dc.contributor.authoraffiliation[de la Cruz Merino, L.] Hosp Univ Virgen Macarena, Oncol, Seville, Spain
dc.contributor.authoraffiliation[Beck, J. T.] Highlands Oncol, Med Oncol, Springdale, AR USA
dc.contributor.authoraffiliation[Zarate, J. P.] Novartis, Oncol, Algiers, Algeria
dc.contributor.authoraffiliation[Wang, Y.] Novartis Pharmaceut, Oncol Dev, Florham Pk, NJ USA
dc.contributor.authoraffiliation[Chakravartty, A.] Novartis Pharmaceut, Oncol, E Hanover, NJ USA
dc.contributor.authoraffiliation[Wang, C.] Novartis Pharma AG, Oncol, Basel, Switzerland
dc.contributor.authoraffiliation[Slamon, D.] Univ Calif Los Angeles, David Geffen Sch Med, Hematol Oncol, Los Angeles, CA 90095 USA
dc.date.accessioned2023-05-03T14:40:35Z
dc.date.available2023-05-03T14:40:35Z
dc.date.issued2022-05-05
dc.identifier.doi10.1016/j.annonc.2022.03.280
dc.identifier.essn1569-8041
dc.identifier.issn0923-7534
dc.identifier.unpaywallURLhttp://www.annalsofoncology.org/article/S092375342200758X/pdf
dc.identifier.urihttp://hdl.handle.net/10668/21910
dc.identifier.wosID792494100163
dc.issue.number3
dc.journal.titleAnnals of oncology
dc.journal.titleabbreviationAnn. oncol.
dc.language.isoen
dc.organizationHospital Universitario Virgen Macarena
dc.organizationHospital Universitario Virgen Macarena
dc.page.numberS194-S194
dc.publisherElsevier
dc.rights.accessRightsopen access
dc.titleUpdated overall survival (OS) results from the first-line (1L) population in the phase III MONALEESA-3 trial of postmenopausal patients (PTS) with HR+/HER2-advanced breast cancer (ABC) treated with ribociclib (RIB) plus fulvestrant (FUL)
dc.typeconference output
dc.type.hasVersionVoR
dc.volume.number33
dc.wostypeMeeting Abstract
dspace.entity.typePublication

Files

Collections

SAS - Hospital Universitario Virgen Macarena

© 2023 – Repositorio Institucional de Salud de Andalucía - Fundación Pública Andaluza Progreso y Salud - Consejería de Salud y Consumo de la Junta de Andalucía